Altogether, the present data underline the crucial role of TAZ in cholangiocarcinogenesis and suggest that targeting TAZ might be an effective therapeutic strategy for the treatment of human iCCA. This evidence concerns the gene WWTR1 and infantile convulsions and choreoathetosis.